XML 39 R30.htm IDEA: XBRL DOCUMENT v2.4.1.9
Share-based Compensation (Tables)
9 Months Ended
Apr. 30, 2015
Share-Based Compensation Expense

The following table presents share-based compensation expense included in our Consolidated Statements of Operations:

 

    Three Months Ended
April 30,
    Nine Months Ended
April 30,
 
(in millions)       2015             2014             2015             2014      

Cost of product sales

  $ 0.2      $ 0.1      $ 0.5      $ 0.5   

Cost of engineering sales

    0.1        0.1        0.2        0.3   

Research and product development

    0.7        0.5        2.0        2.0   

Selling and marketing

    0.4        0.3        1.1        0.9   

General and administrative

    2.0        1.9        4.6        5.0   

Total share-based compensation expense before tax

    3.4        2.9        8.4        8.7   

Income tax effect

    (1.0     (0.9     (2.5     (2.7

Share-based compensation expense included in net income

  $ 2.4      $ 2.0      $ 5.9      $ 6.0   

 

Fair Value of Option Grant Assumptions
The fair value of each option granted during the nine months ended April 30, 2015 and during the three and nine months ended April 30, 2014 was estimated on the grant date using the Black-Scholes valuation model with the following assumptions:

 

     Three Months Ended     Nine Months Ended  
     April 30,     April 30,  
             2015                      2014                     2015                     2014          

Expected option term in years (1)

     -         5.31        5.31        5.37   

Expected volatility (2)

     -         35.1     29.3     38.6

Risk-free interest rate (3)

     -         1.51     1.82     1.77

Expected annual dividend yield (4)

     -         0.42     0.56     0.52

Weighted average grant date fair value

     -       $ 30.80      $ 19.95      $ 27.55   

 

(1) The expected option term was estimated using historical data.
(2) The expected volatility for each grant is determined based on the review of the average of historical daily price changes of our common stock over the expected option term.
(3) The risk free interest rate for periods equal to the expected term of the stock option is based on the U.S. Treasury yield curve in effect at the time of grant.
(4) The expected annual dividend yield is calculated by dividing the expected annual dividends by the stock price on the date of grant.
Fair Value of Awards Grant Assumptions

The fair value of our non-GAAP EPS performance-based awards was estimated using the quoted closing price of our common stock on the date of grant. The fair value of our TSR performance-based awards at the date of grant was estimated using the Monte-Carlo simulation model with the following assumptions:

 

     Three Months Ended     Nine Months Ended  
     April 30,     April 30,  
     2015     2014     2015     2014  

Stock price (1)

   $ 87.50      $ 94.32      $ 71.33      $ 77.14   

Expected volatility (2)

     27.6     27.5     29.3     27.6

Risk-free interest rate (3)

     0.83     0.46     1.00     0.82

Expected annual dividend yield (4)

     0.00     0.00     0.00     0.00

Weighted average grant date fair value of performance based restricted stock awards

   $ 127.52      $ 117.61      $ 88.00      $ 93.85   

 

(1) The stock price is the closing price of our common stock on the date of grant.
(2) The expected volatility for each grant is determined based on the historical volatility for the peer group companies and our common stock over a period equal to the remaining term of the performance period from the date of grant for all awards.
(3) The risk free interest rate for periods equal to the performance period is based on the U.S. Treasury yield curve in effect at the time of grant.
(4) Dividends are considered reinvested when calculating TSR. The dividend yield is therefore considered to be 0%.